Skip to navigation Skip to main content

RUBRACA (rucaparib) for Ovarian Cancer

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews drug information for RUBRACA (rucaparib), indicated for ovarian cancer.

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide 7: Use in Specific Populations
Slide 11: Clinical Pharmacology
Slide 15: Warnings and Precautions
Slide 19: Clinical Safety and Efficacy
Slide 25: Drug Storage and Supply
Slide 28: References

Topics:

Drug Showcase Gynecologic Cancers Ovarian Cancer
  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More